InvestorsHub Logo
Followers 0
Posts 342
Boards Moderated 0
Alias Born 08/12/2009

Re: liltrader post# 5657

Friday, 10/02/2009 11:21:18 PM

Friday, October 02, 2009 11:21:18 PM

Post# of 333985
I think BIEL has the potential over the long term to be a $1 + stock. FDA approval will give BIEL the ability to target markets with hugh revenue opportunities, which currently are unavailable to them. Right now the patch has approval for a very small amount of uses, with limited markets, and limited upside for revenue growth. The BIEL PEMF patch is a viable and beneficial product with practical uses. If BIEL is successful in obtaining FDA approval to diversify the use of this patch, the revenue potential could be huge, assuming they are successful at navigating their way into these markets. This technology has been around for awhile and the critics have complained that the technology just hasn't caught on, and that people are unwilling to adopt this type of pain treatment when it is so much easier to swallow a pill. I think that is partly true because of the limited uses of this patch right now, and the fact that people are unwilling to try different things, however if the patch is eventually granted the additional approvals that BIEL is seeking from the FDA, use of the patch hopefully will be able to address pain and inflammation associated with medical surgeries, chronic wounds, oral surgeries, sprains, strains, lower back pain, as well as chronic repetitive stress injuries and folks will have a much more effective and less costly means of treating their problems. This potentially could hold huge untapped sources of revenues for BIEL. Everything hinges on FDA approvals, success could mean big revenue, but BIEL will have to get the word out. If they can convince people that the product is a better alternative to pills and if everything else falls into place the PPS could reflect dollars rather than cents.